Propel Bio Management, LLC 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Propel Bio Management, LLC disclosed 16 US equity positions worth $99.9m in its Q3 2025 13F filing. The largest position was PAGPEUR at 23.2% of the reported book, followed by ACHV and AKERO THERAPEUTICS INC. Against the Q2 2025 filing, it opened 6 new positions, added to 2 and reduced 3 among the top 16 holdings.
What did Propel Bio Management, LLC own in Q3 2025? Top 16 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | PAGPEUR PLAINS GP HOLDINGS LP-CL | 23.2% | $23.2m | 1,272,360 | 0% | held | |
| 2 | ACHV ACHIEVE LIFE SCIENCES INC | 11.9% | $11.9m | 3,786,425 | -38% | reduced | |
| 3 | AKERO THERAPEUTICS INC | 10.9% | $10.9m | 228,884 | 0% | held | |
| 4 | MIST MILESTONE PHARMACEUTICALS | 10.3% | $10.2m | 5,124,890 | 186% | added | |
| 5 | APLT APPLIED THERAPEUTICS INC | 6.8% | $6.8m | 11,285,420 | 0% | held | |
| 6 | PHAT PHATHOM PHARMACEUTICALS I | 6.5% | $6.5m | 552,927 | -40% | reduced | |
| 7 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 5.1% | $5.1m | 974,022 | 0% | held |
| 8 | DCTH DELCATH SYSTEMS INC | 4.7% | $4.7m | 438,509 | 94% | added | |
| 9 | CLDX CELLDEX THERAPEUTICS INC | Healthcare | 4.0% | $4.0m | 155,000 | – | new |
| 10 | TCRX TSCAN THERAPEUTICS INC | 3.5% | $3.5m | 1,932,304 | -7% | reduced | |
| 11 | CMPS COMPASS PATHWAYS PLC | Healthcare | 2.9% | $2.9m | 510,000 | – | new |
| 12 | NKTR NEKTAR THERAPEUTICS | Healthcare | 2.8% | $2.8m | 49,000 | – | new |
| 13 | JSPR JASPER THERAPEUTICS INC | 2.5% | $2.4m | 1,028,806 | – | new | |
| 14 | ZVRA ZEVRA THERAPEUTICS INC | 2.2% | $2.2m | 231,874 | 0% | held | |
| 15 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 1.9% | $1.9m | 90,000 | – | new |
| 16 | LONA ATHIRA PHARMA INC | 0.6% | $618.0k | 149,279 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.